Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 24% ± 8% | |
ciliated cell | 5 studies | 26% ± 5% | |
astrocyte | 4 studies | 25% ± 4% | |
fibroblast | 3 studies | 21% ± 7% | |
oligodendrocyte precursor cell | 3 studies | 22% ± 3% | |
club cell | 3 studies | 18% ± 2% | |
oligodendrocyte | 3 studies | 23% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 22% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 1312.77 | 245 / 245 | 100% | 3.86 | 501 / 502 |
ovary | 100% | 1672.94 | 180 / 180 | 100% | 3.70 | 429 / 430 |
thymus | 100% | 1218.53 | 653 / 653 | 99% | 4.38 | 599 / 605 |
brain | 98% | 366.27 | 2595 / 2642 | 100% | 5.10 | 702 / 705 |
breast | 100% | 974.71 | 459 / 459 | 96% | 3.57 | 1078 / 1118 |
kidney | 100% | 688.08 | 89 / 89 | 95% | 3.27 | 859 / 901 |
pancreas | 100% | 550.37 | 327 / 328 | 96% | 2.44 | 170 / 178 |
esophagus | 99% | 808.90 | 1434 / 1445 | 93% | 2.31 | 171 / 183 |
adrenal gland | 100% | 704.76 | 258 / 258 | 93% | 2.28 | 213 / 230 |
lung | 99% | 589.01 | 571 / 578 | 86% | 2.09 | 993 / 1155 |
stomach | 100% | 762.09 | 359 / 359 | 83% | 1.87 | 238 / 286 |
skin | 94% | 540.63 | 1697 / 1809 | 87% | 2.60 | 412 / 472 |
uterus | 100% | 1304.78 | 170 / 170 | 76% | 1.83 | 348 / 459 |
intestine | 100% | 949.92 | 966 / 966 | 76% | 1.58 | 399 / 527 |
liver | 100% | 514.10 | 226 / 226 | 75% | 1.48 | 303 / 406 |
bladder | 100% | 1059.67 | 21 / 21 | 74% | 1.61 | 375 / 504 |
spleen | 100% | 750.50 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 759.14 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 686.44 | 801 / 803 | 0% | 0 | 0 / 0 |
adipose | 100% | 775.04 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 459.59 | 835 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 84% | 2.37 | 67 / 80 |
peripheral blood | 62% | 138.95 | 573 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 58% | 1.01 | 26 / 45 |
lymph node | 0% | 0 | 0 / 0 | 55% | 0.87 | 16 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
Gene name | GTF2IRD2B |
Protein name | GTF2I repeat domain containing 2B GTF2IRD2B protein General transcription factor II-I repeat domain-containing protein 2B (GTF2I repeat domain-containing protein 2B) (Transcription factor GTF2IRD2-beta) |
Synonyms | |
Description | |
Accessions | ENST00000418185.6 [Q6EKJ0-2] ENST00000472837.7 [Q6EKJ0-1] Q86Y00 A0A087WW90 A0A494C1N8 Q6EKJ0 ENST00000619142.4 ENST00000651028.1 |